Cafepharma Today

October 28 2024 - Where Big Pharma’s campaign cash is flowing in this election
Where Big Pharma’s campaign cash is flowing in this election
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
Apple wins a mere $250 from Masimo in watch patent trial
After Pfizer deal, former Seagen CEO returns to lead oncology startup
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts
BioSpace
Monday, October 28, 2024 - 6:27pm
tags:
Revolution Medicines, pancreatic cancer, RAS inhibitors
After prior trial flop, EyePoint's Duravyu bounces back with promising data in DME
Fierce Pharma
Monday, October 28, 2024 - 6:25pm
tags:
Eyepoint, Duravyu, drug-device combos, diabetic macular edema
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Monday, October 28, 2024 - 6:24pm
tags:
Eli Lilly, JNJ, Crohn's Disease, FDA, clinical trials, Tremfya, Omvoh
CVS workers in California reach tentative labor deal
Beckers Hospital Review
Monday, October 28, 2024 - 6:22pm
tags:
CVS, pharmacies, labor strike, California
J&J Reports Positive Data in Impella ECP Trial
Medical Devices and Diagnostics Industry
Monday, October 28, 2024 - 6:18pm
tags:
Abiomed, JNJ, Johnson & Johnson MedTech, Imprella ECP, medtehc
Astellas doesn't see eye to eye with Europe on geographic atrophy drug Izervay
Fierce Pharma
Monday, October 28, 2024 - 6:12pm
tags:
Astellas, Izervay, Apellis, Syfovre, geographic atrophy, Europe
Where Big Pharma’s campaign cash is flowing in this election
Pharma Voice
Monday, October 28, 2024 - 11:43am
tags:
2024 Presidential election, PACs, pharma industry, campaign donations
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
BioSpace
Monday, October 28, 2024 - 11:41am
tags:
AbbVie, M&A, Alzheimer's disease, Aliada Therapeutics
Apple wins a mere $250 from Masimo in watch patent trial
TechCrunch
Monday, October 28, 2024 - 11:39am
tags:
Medtech, Apple, Masimo, patents, smartwatch, legal
Monte Rosa joins with Novartis in ‘molecular glue’ drug deal
BioPharma Dive
Monday, October 28, 2024 - 11:36am
tags:
Novartis, molecular glue degrader, Monte Rosa
Pharma companies must adapt to keep pace with AI developments, say experts
Clinical Trials Arena
Monday, October 28, 2024 - 11:22am
tags:
artificial intelligence, clinical trials
Fog clears to reveal Parabilis, a rebranded cancer biotech with big name backers
Fierce Pharma
Monday, October 28, 2024 - 11:19am
tags:
FogPharma, Parabilis Medicines, rebranded
Maze Therapeutics reports positive data from Phase I AKD treatment trial
Clinical Trials Arena
Monday, October 28, 2024 - 11:17am
tags:
Maze Therapeutics, MZE829, kidney disease, clinical trials
After Pfizer deal, former Seagen CEO returns to lead oncology startup
BioPharma Dive
Monday, October 28, 2024 - 11:10am
tags:
David Epstein, Ottimo Pharma, Seagen, oncology, cancer immunotherapy
In pain R&D, Vertex withstood tough times to bring non-opioid suzetrigine to cusp of FDA approval
Fierce Biotech
Monday, October 28, 2024 - 10:20am
tags:
Vertex Pharmaceuticals, R&D, non-opioid pain treatments, suzetrigine
Biogen shows its IgAN hand with felzartamab data
Pharmaphorum
Monday, October 28, 2024 - 10:19am
tags:
Biogen, clinical trials, kidney disease, felzartamab, IgA nephropathy
Novartis eyes year-end filing in US for Fabhalta in C3G
Pharmaphorum
Monday, October 28, 2024 - 10:17am
tags:
Novartis, Fabalta, kidney disease, C3 glomerulopathy
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Fierce Pharma
Sunday, October 27, 2024 - 7:48pm
tags:
Iterum, antibiotics, UTIs, FDA, Orlynvah
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings
Yahoo/Zacks.com
Sunday, October 27, 2024 - 7:47pm
tags:
earnings, Bristol Myers Squibb
IDEAYA reports Phase 1 expansion data for IDE397
MSN/Seeking Alpha
Sunday, October 27, 2024 - 7:45pm
tags:
Ideaya, clinical trials, IDE397, MTAP, urothelial cancer, lung cancer

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline

Latest Jobs

Pharmaceutical Sales Customer Engagement- Phoenix, AZ
Phoenix, Arizona,
Otsuka
Account Manager-Queens West, NY-Ophthalmics
Rego Park, New York, 11374
Sun Pharmaceutical Industries, Inc.
Account Manager-Queens West, NY-Ophthalmics
East Orange, New Jersey, 07017
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement - San Diego S, CA
San Diego, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Thousand Oaks, CA
Thousand Oaks, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia,
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Portland E, OR
Portland, Oregon,
Otsuka
Psychiatry Account Manager - Greenville West, SC
Greenville, South Carolina, US
Lundbeck
Account Manager-Queens West, NY-Ophthalmics
Passaic, New Jersey, 07055
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information